- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Psoriasis Therapeutics industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
AstraZeneca plc
Valeant Pharmaceuticals International, Inc
Eli Lilly and Company
Merck & Co, Inc
Biocon Limited
GlaxoSmithKline plc
F Hofffmann-La Roche
Boehringer Ingelheim GmbH
Astellas Pharma Inc
By Type:
Parenteral
Topical
Oral
By Application:
TNF Inhibitors
PDE4 Inhibitors
Interleukin Blockers
Others
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Psoriasis Therapeutics Market Overview 2018-2029
-
1.1 China Psoriasis Therapeutics Industry Development Overview
-
1.2 China Psoriasis Therapeutics Industry Development History
-
1.3 China Psoriasis Therapeutics Industry Market Size (2018-2029)
-
1.4 China Psoriasis Therapeutics Market Analysis by Type from Production Side
-
1.4.1 China Psoriasis Therapeutics Production Volume, Production Value and Growth Rate of Parenteral (2018-2029)
-
1.4.2 China Psoriasis Therapeutics Production Volume, Production Value and Growth Rate of Topical (2018-2029)
-
1.4.3 China Psoriasis Therapeutics Production Volume, Production Value and Growth Rate of Oral (2018-2029)
-
1.5 China Psoriasis Therapeutics Market Analysis by Application from Consumption End
-
1.5.1 China Psoriasis Therapeutics Sales Volume, Sales Value and Growth Rate of TNF Inhibitors (2018-2029)
-
1.5.2 China Psoriasis Therapeutics Sales Volume, Sales Value and Growth Rate of PDE4 Inhibitors (2018-2029)
-
1.5.3 China Psoriasis Therapeutics Sales Volume, Sales Value and Growth Rate of Interleukin Blockers (2018-2029)
-
1.5.4 China Psoriasis Therapeutics Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
1.6 China Psoriasis Therapeutics Market Analysis by Region
-
1.6.1 North China Psoriasis Therapeutics Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Psoriasis Therapeutics Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Psoriasis Therapeutics Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Psoriasis Therapeutics Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Psoriasis Therapeutics Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Psoriasis Therapeutics Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Psoriasis Therapeutics Market Size and Growth Rate from 2018-2029
Chapter 2 China Psoriasis Therapeutics Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Psoriasis Therapeutics Market Status and Competition at home and abroad in 2023
-
2.2.2 China Psoriasis Therapeutics Market Status and Competition Analysis in 2023
-
2.2.3 China Psoriasis Therapeutics Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Psoriasis Therapeutics Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Psoriasis Therapeutics Industry Development
Chapter 3 Psoriasis TherapeuticsIndustry Chain Analysis
-
3.1 Psoriasis Therapeutics Industry Chain
-
3.2 Psoriasis Therapeutics Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Psoriasis Therapeutics Market
-
3.3 Psoriasis Therapeutics Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Psoriasis Therapeutics Market
Chapter 4 China Psoriasis Therapeutics Market, by Type
-
4.1 China Psoriasis Therapeutics Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Psoriasis Therapeutics Total Production Volume and Growth Rate from Production Side
-
4.5 China Psoriasis Therapeutics Production Volume and Growth Rate, by Type
-
4.5.1 China Psoriasis Therapeutics Production Volume and Growth Rate of Parenteral
-
4.5.2 China Psoriasis Therapeutics Production Volume and Growth Rate of Topical
-
4.5.3 China Psoriasis Therapeutics Production Volume and Growth Rate of Oral
Chapter 5 China Psoriasis Therapeutics Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Psoriasis Therapeutics Total Market Size and Growth Rate from Consumption End
-
5.5 China Psoriasis Therapeutics Market Size and Growth Rate, by Application
-
5.5.1 China Psoriasis Therapeutics Market Size and Growth Rate of TNF Inhibitors
-
5.5.2 China Psoriasis Therapeutics Market Size and Growth Rate of PDE4 Inhibitors
-
5.5.3 China Psoriasis Therapeutics Market Size and Growth Rate of Interleukin Blockers
-
5.5.4 China Psoriasis Therapeutics Market Size and Growth Rate of Others
Chapter 6 China Psoriasis Therapeutics Market, by Region
-
6.1 China Psoriasis Therapeutics Production Volume and Production Value, by Region
-
6.2 China Psoriasis Therapeutics Sales Volume and Sales Value, by Region
Chapter 7 North China Psoriasis Therapeutics Market Analysis
-
7.1 North China Psoriasis Therapeutics Market, by Type
-
7.2 North China Psoriasis Therapeutics Market, by Application
Chapter 8 Central China Psoriasis Therapeutics Market Analysis
-
8.1 Central China Psoriasis Therapeutics Market, by Type
-
8.2 Central China Psoriasis Therapeutics Market, by Application
Chapter 9 South China Psoriasis Therapeutics Market Analysis
-
9.1 South China Psoriasis Therapeutics Market, by Type
-
9.2 South China Psoriasis Therapeutics Market, by Application
Chapter 10 East China Psoriasis Therapeutics Market Analysis
-
10.1 East China Psoriasis Therapeutics Market, by Type
-
10.2 East China Psoriasis Therapeutics Market, by Application
Chapter 11 Northeast China Psoriasis Therapeutics Market Analysis
-
11.1 Northeast China Psoriasis Therapeutics Market, by Type
-
11.2 Northeast China Psoriasis Therapeutics Market, by Application
Chapter 12 Southwest China Psoriasis Therapeutics Market Analysis
-
12.1 Southwest China Psoriasis Therapeutics Market, by Type
-
12.2 Southwest China Psoriasis Therapeutics Market, by Application
Chapter 13 Northwest China Psoriasis Therapeutics Market Analysis
-
13.1 Northwest China Psoriasis Therapeutics Market, by Type
-
13.2 Northwest China Psoriasis Therapeutics Market, by Application
Chapter 14 Company Profiles
-
14.1 AstraZeneca plc
-
14.1.1 AstraZeneca plc Company Profile
-
14.1.2 AstraZeneca plc Psoriasis Therapeutics Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Valeant Pharmaceuticals International, Inc
-
14.2.1 Valeant Pharmaceuticals International, Inc Company Profile
-
14.2.2 Valeant Pharmaceuticals International, Inc Psoriasis Therapeutics Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Eli Lilly and Company
-
14.3.1 Eli Lilly and Company Company Profile
-
14.3.2 Eli Lilly and Company Psoriasis Therapeutics Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Merck & Co, Inc
-
14.4.1 Merck & Co, Inc Company Profile
-
14.4.2 Merck & Co, Inc Psoriasis Therapeutics Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Biocon Limited
-
14.5.1 Biocon Limited Company Profile
-
14.5.2 Biocon Limited Psoriasis Therapeutics Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 GlaxoSmithKline plc
-
14.6.1 GlaxoSmithKline plc Company Profile
-
14.6.2 GlaxoSmithKline plc Psoriasis Therapeutics Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 F Hofffmann-La Roche
-
14.7.1 F Hofffmann-La Roche Company Profile
-
14.7.2 F Hofffmann-La Roche Psoriasis Therapeutics Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Boehringer Ingelheim GmbH
-
14.8.1 Boehringer Ingelheim GmbH Company Profile
-
14.8.2 Boehringer Ingelheim GmbH Psoriasis Therapeutics Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Astellas Pharma Inc
-
14.9.1 Astellas Pharma Inc Company Profile
-
14.9.2 Astellas Pharma Inc Psoriasis Therapeutics Market Performance
-
14.9.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Psoriasis Therapeutics Industry Research Conclusions
-
15.2 Psoriasis Therapeutics Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Psoriasis Therapeutics Industry Market Size (2018-2029)
-
Figure China Psoriasis Therapeutics Production Volume, Production Value and Growth Rate of Parenteral (2018-2029)
-
Figure China Psoriasis Therapeutics Production Volume, Production Value and Growth Rate of Topical (2018-2029)
-
Figure China Psoriasis Therapeutics Production Volume, Production Value and Growth Rate of Oral (2018-2029)
-
Figure China Psoriasis Therapeutics Sales Volume, Sales Value and Growth Rate of TNF Inhibitors (2018-2029)
-
Figure China Psoriasis Therapeutics Sales Volume, Sales Value and Growth Rate of PDE4 Inhibitors (2018-2029)
-
Figure China Psoriasis Therapeutics Sales Volume, Sales Value and Growth Rate of Interleukin Blockers (2018-2029)
-
Figure China Psoriasis Therapeutics Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
Figure North China Psoriasis Therapeutics Market Size and Growth Rate from 2018-2029
-
Figure Central China Psoriasis Therapeutics Market Size and Growth Rate from 2018-2029
-
Figure South China Psoriasis Therapeutics Market Size and Growth Rate from 2018-2029
-
Figure East China Psoriasis Therapeutics Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Psoriasis Therapeutics Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Psoriasis Therapeutics Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Psoriasis Therapeutics Market Size and Growth Rate from 2018-2029
-
Figure Psoriasis Therapeutics Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Psoriasis Therapeutics Market Share by Type in 2018
-
Figure China Psoriasis Therapeutics Market Share by Type in 2023
-
Figure China Psoriasis Therapeutics Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Psoriasis Therapeutics Production Volume and Growth Rate of Parenteral (2018-2023)
-
Figure China Psoriasis Therapeutics Production Volume and Growth Rate of Topical (2018-2023)
-
Figure China Psoriasis Therapeutics Production Volume and Growth Rate of Oral (2018-2023)
-
Figure China Psoriasis Therapeutics Market Share by Application in 2018
-
Figure China Psoriasis Therapeutics Market Share by Application in 2023
-
Figure China Psoriasis Therapeutics Total Market Size and Growth Rate from Consumption End
-
Figure China Psoriasis Therapeutics Market Size and Growth Rate of TNF Inhibitors (2018-2023)
-
Figure China Psoriasis Therapeutics Market Size and Growth Rate of PDE4 Inhibitors (2018-2023)
-
Figure China Psoriasis Therapeutics Market Size and Growth Rate of Interleukin Blockers (2018-2023)
-
Figure China Psoriasis Therapeutics Market Size and Growth Rate of Others (2018-2023)
-
Table China Psoriasis Therapeutics Production Volume by Region (2018-2023)
-
Table China Psoriasis Therapeutics Production Volume Share by Region (2018-2023)
-
Figure China Psoriasis Therapeutics Production Volume Share by Region (2018-2023)
-
Table China Psoriasis Therapeutics Production Value by Region (2018-2023)
-
Table China Psoriasis Therapeutics Production Value Share by Region (2018-2023)
-
Figure China Psoriasis Therapeutics Production Value Share by Region (2018-2023)
-
Table China Psoriasis Therapeutics Sales Volume by Region (2018-2023)
-
Table China Psoriasis Therapeutics Sales Volume Share by Region (2018-2023)
-
Figure China Psoriasis Therapeutics Sales Volume Share by Region (2018-2023)
-
Table China Psoriasis Therapeutics Sales Value by Region (2018-2023)
-
Table China Psoriasis Therapeutics Sales Value Share by Region (2018-2023)
-
Figure China Psoriasis Therapeutics Sales Value Share by Region (2018-2023)
-
Table North China Psoriasis Therapeutics Production Volume by Type (2018-2023)
-
Table North China Psoriasis Therapeutics Production Volume Share by Type (2018-2023)
-
Figure North China Psoriasis Therapeutics Production Volume Share by Type (2018-2023)
-
Table North China Psoriasis Therapeutics Sales Volume by Application (2018-2023)
-
Table North China Psoriasis Therapeutics Sales Volume Share by Application (2018-2023)
-
Figure North China Psoriasis Therapeutics Sales Volume Share by Application (2018-2023)
-
Table Central China Psoriasis Therapeutics Production Volume by Type (2018-2023)
-
Table Central China Psoriasis Therapeutics Production Volume Share by Type (2018-2023)
-
Figure Central China Psoriasis Therapeutics Production Volume Share by Type (2018-2023)
-
Table Central China Psoriasis Therapeutics Sales Volume by Application (2018-2023)
-
Table Central China Psoriasis Therapeutics Sales Volume Share by Application (2018-2023)
-
Figure Central China Psoriasis Therapeutics Sales Volume Share by Application (2018-2023)
-
Table South China Psoriasis Therapeutics Production Volume by Type (2018-2023)
-
Table South China Psoriasis Therapeutics Production Volume Share by Type (2018-2023)
-
Figure South China Psoriasis Therapeutics Production Volume Share by Type (2018-2023)
-
Table South China Psoriasis Therapeutics Sales Volume by Application (2018-2023)
-
Table South China Psoriasis Therapeutics Sales Volume Share by Application (2018-2023)
-
Figure South China Psoriasis Therapeutics Sales Volume Share by Application (2018-2023)
-
Table East China Psoriasis Therapeutics Production Volume by Type (2018-2023)
-
Table East China Psoriasis Therapeutics Production Volume Share by Type (2018-2023)
-
Figure East China Psoriasis Therapeutics Production Volume Share by Type (2018-2023)
-
Table East China Psoriasis Therapeutics Sales Volume by Application (2018-2023)
-
Table East China Psoriasis Therapeutics Sales Volume Share by Application (2018-2023)
-
Figure East China Psoriasis Therapeutics Sales Volume Share by Application (2018-2023)
-
Table Northeast China Psoriasis Therapeutics Production Volume by Type (2018-2023)
-
Table Northeast China Psoriasis Therapeutics Production Volume Share by Type (2018-2023)
-
Figure Northeast China Psoriasis Therapeutics Production Volume Share by Type (2018-2023)
-
Table Northeast China Psoriasis Therapeutics Sales Volume by Application (2018-2023)
-
Table Northeast China Psoriasis Therapeutics Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Psoriasis Therapeutics Sales Volume Share by Application (2018-2023)
-
Table Southwest China Psoriasis Therapeutics Production Volume by Type (2018-2023)
-
Table Southwest China Psoriasis Therapeutics Production Volume Share by Type (2018-2023)
-
Figure Southwest China Psoriasis Therapeutics Production Volume Share by Type (2018-2023)
-
Table Southwest China Psoriasis Therapeutics Sales Volume by Application (2018-2023)
-
Table Southwest China Psoriasis Therapeutics Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Psoriasis Therapeutics Sales Volume Share by Application (2018-2023)
-
Table Northwest China Psoriasis Therapeutics Production Volume by Type (2018-2023)
-
Table Northwest China Psoriasis Therapeutics Production Volume Share by Type (2018-2023)
-
Figure Northwest China Psoriasis Therapeutics Production Volume Share by Type (2018-2023)
-
Table Northwest China Psoriasis Therapeutics Sales Volume by Application (2018-2023)
-
Table Northwest China Psoriasis Therapeutics Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Psoriasis Therapeutics Sales Volume Share by Application (2018-2023)
-
Table AstraZeneca plc Company Profile
-
Table AstraZeneca plc Psoriasis Therapeutics Revenue, Price and Gross (2018-2023)
-
Table Valeant Pharmaceuticals International, Inc Company Profile
-
Table Valeant Pharmaceuticals International, Inc Psoriasis Therapeutics Revenue, Price and Gross (2018-2023)
-
Table Eli Lilly and Company Company Profile
-
Table Eli Lilly and Company Psoriasis Therapeutics Revenue, Price and Gross (2018-2023)
-
Table Merck & Co, Inc Company Profile
-
Table Merck & Co, Inc Psoriasis Therapeutics Revenue, Price and Gross (2018-2023)
-
Table Biocon Limited Company Profile
-
Table Biocon Limited Psoriasis Therapeutics Revenue, Price and Gross (2018-2023)
-
Table GlaxoSmithKline plc Company Profile
-
Table GlaxoSmithKline plc Psoriasis Therapeutics Revenue, Price and Gross (2018-2023)
-
Table F Hofffmann-La Roche Company Profile
-
Table F Hofffmann-La Roche Psoriasis Therapeutics Revenue, Price and Gross (2018-2023)
-
Table Boehringer Ingelheim GmbH Company Profile
-
Table Boehringer Ingelheim GmbH Psoriasis Therapeutics Revenue, Price and Gross (2018-2023)
-
Table Astellas Pharma Inc Company Profile
-
Table Astellas Pharma Inc Psoriasis Therapeutics Revenue, Price and Gross (2018-2023)
-